Are you looking for recent Pharma Magazine information?
Check out the Top News in Pharma Magazine, Leading Magazine in the Pharma Industry, and most recent pharmaceutical news. Daily information updates related to the industrial sectors we work in are presented in the pharmaceutical industry's news area
KSQ Therapeutics Inc recently obtained FDA clearance for an Investigational New Drug IND application for its Phase clinical study of KSQEX an engineered tumorinfiltrating lymphocyte
Verge Genomics a biotechnology company in the clinical stage is transforming drug discovery through the integration of artificial intelligence and human data The company has announced that its Phase b proofofconcept
Evaxion Biotech AS is thrilled to present its innovative precision vaccine concept at the upcoming th Annual Meeting of the American Society of Hematology
Thermo Fisher Scientific Inc and Flagship Pioneering have recently announced a strategic partnership to expedite the development and commercial scaling of multiproduct platforms
Evommune Inc a biotechnology company dedicated to exploring and advancing new methods for treating immunemediated inflammatory diseases has joined forces with Accutar Biotechnology Inc a company specializing in AIaided drug discovery
OncoNano Medicine Inc has announced the initiation of its Phase clinical trial at the University of Pittsburgh Medical Center
Myricx Bio a biotechnology company based in the UK is delighted to announce the publication of groundbreaking research in Nature Cell Biology by collaborators at the MRCLMS The research reveals the central role of NMyristoyltransferase
EnGeneIC a leader in personalized cancer treatments has revealed the outcomes of its clinical trial in the esteemed journal Clinical Cancer Research by the American Association for Cancer Research
ABIONYX Pharma a forwardthinking biotech company committed to advancing therapies utilizing the worlds only natural recombinant apoAI is set to unveil novel preclinical findings on CERs
Merz Therapeutics a division of the Merz Group and a leading player in neurotoxin research has secured approval from the Australian Therapeutic Goods Administration for the use of XEOMIN
